Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE PHARMACY AUTOMATION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 EUROPE PHARMACY AUTOMATION MARKET: REGULATIONS
4.1 EXISTING STATE LAWS AND REGULATIONS FOR THE USE OF AUTOMATED DISPENSING SYSTEMS (ADS) IN THE U.S.
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING NEED TO MINIMIZE MEDICATION ERRORS
5.1.2 RISING DEMAND FOR PHARMACEUTICALS
5.1.3 RISING LABOR COST
5.1.4 ADVANTAGES OF PHARMACY AUTOMATION SYSTEMS OVER MANUAL METHODS
5.1.5 TECHNOLOGICAL ADVANCEMENTS AND PRECISE ROBOTIC TOOLS
5.2 RESTRAINTS
5.2.1 RELUCTANCE AMONG THE HEALTHCARE ORGANIZATIONS TO ADOPT PHARMACY AUTOMATION SYSTEMS
5.2.2 HIGH CAPITAL INVESTMENT
5.2.3 INTEROPERABILITY PROBLEMS IN PHARMACY AUTOMATION
5.3 OPPORTUNITIES
5.3.1 NEED FOR INCREASING THE EFFICIENCY OF WORK WITHIN THE PHARMACIES
5.3.2 RISING HEALTHCARE EXPENDITURE IN EMERGING NATIONS
5.3.3 STRATEGIC INITIATIVES OF KEY MARKET PLAYERS
5.4 CHALLENGES
5.4.1 STRINGENCY OF REGULATORY PROCEDURES
5.4.2 SKILLED WORK-FORCE CHALLENGES
5.4.3 LIMITATIONS OF PHARMACY AUTOMATION SYSTEMS
6 EUROPE PHARMACY AUTOMATION MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SYSTEMS
6.3 SOFTWARE
6.4 SERVICES
7 EUROPE PHARMACY AUTOMATION MARKET, BY PHARMACY TYPE
7.1 OVERVIEW
7.2 INDEPENDENT
7.3 CHAIN
7.4 FEDERAL
8 EUROPE PHARMACY AUTOMATION MARKET, BY PHARMACY SIZE
8.1 OVERVIEW
8.2 LARGE SIZE PHARMACY
8.3 MEDIUM SIZE PHARMACY
8.4 SMALL SIZE PHARMACY
9 EUROPE PHARMACY AUTOMATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISPENSING AND PACKAGING
9.3 DRUG STORAGE
9.4 INVENTORY MANAGEMENT
10 EUROPE PHARMACY AUTOMATION MARKET, BY END USER
10.1 OVERVIEW
10.2 INPATIENT PHARMACIES
10.3 OUTPATIENT PHARMACIES
10.4 RETAIL PHARMACIES
10.5 ONLINE PHARMACIES
10.6 CENTRAL FILL/MAIL ORDER PHARMACIES
10.7 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS
10.8 OTHERS
11 EUROPE PHARMACY AUTOMATION MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTOR
12 EUROPE PHARMACY AUTOMATION MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 ITALY
12.1.4 U.K.
12.1.5 SPAIN
12.1.6 SWITZERLAND
12.1.7 RUSSIA
12.1.8 NETHERLANDS
12.1.9 BELGIUM
12.1.10 TURKEY
12.1.11 REST OF EUROPE
13 EUROPE PHARMACY AUTOMATION MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 OMNICELL, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 MCKESSON CORPORATION
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 AMERISOURCEBERGEN CORPORATION
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 BAXTER
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 TOSHO CO., INC.
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 APD ALGORITMOS PROCESOS Y DISEÑOS S.A.
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ASTERES INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ARXIUM
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 BD
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 COMPANY SHARE ANALYSIS
15.9.4 PRODUCT PORTFOLIO
15.9.5 RECENT DEVELOPMENTS
15.1 BIQHS
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 CAPSA HEALTHCARE
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 CERNER CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 DEENOVA S.R.L.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 DEMODEKS PHARMACY SHELVING
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 FULLSCRIPT
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 GENESIS AUTOMATION LTD
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 IA
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 INTERLINK AI, INC
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 JVM EUROPE BV
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 KLS PHARMA ROBOTICS GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 KUKA AG
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 COMPANY SHARE ANALYSIS
15.21.4 PRODUCT PORTFOLIO
15.21.5 RECENT DEVELOPMENTS
15.22 MEDAVAIL TECHNOLOGIES, INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 MYPAK SOLUTIONS PTY LTD.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 RXSAFE, LLC.
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 SCRIPTPRO LLC
15.25.1 COMPANY SNAPSHOT
15.25.2 COMPANY SHARE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENTS
15.26 SYNERGY MEDICAL
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
15.27 TAKAZONO CORPORATION
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
15.28 UNIVERSAL LOGISTICS HOLDINGS, INC.
15.28.1 COMPANY SNAPSHOT
15.28.2 REVENUE ANALYSIS
15.28.3 PRODUCT PORTFOLIO
15.28.4 RECENT DEVELOPMENTS
15.29 WILLACH GROUP
15.29.1 COMPANY SNAPSHOT
15.29.2 PRODUCT PORTFOLIO
15.29.3 RECENT DEVELOPMENTS
15.3 YUYAMA
15.30.1 COMPANY SNAPSHOT
15.30.2 PRODUCT PORTFOLIO
15.30.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Figure
FIGURE 1 EUROPE PHARMACY AUTOMATION MARKET: SEGMENTATION
FIGURE 2 EUROPE PHARMACY AUTOMATION MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PHARMACY AUTOMATION MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PHARMACY AUTOMATION MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PHARMACY AUTOMATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PHARMACY AUTOMATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE PHARMACY AUTOMATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE PHARMACY AUTOMATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE PHARMACY AUTOMATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE PHARMACY AUTOMATION MARKET: SEGMENTATION
FIGURE 11 GROWING NEED TO MINIMIZE MEDICATION ERRORS IS EXPECTED TO DRIVE THE EUROPE PHARMACY AUTOMATION MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACY AUTOMATION MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PHARMACY AUTOMATION MARKET
FIGURE 14 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, 2022
FIGURE 15 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, 2023-2030 (USD
FIGURE 16 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, 2022
FIGURE 19 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, 2022
FIGURE 23 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, CAGR (2023-2030)
FIGURE 25 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, LIFELINE CURVE
FIGURE 26 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, 2022
FIGURE 27 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 29 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, 2022
FIGURE 31 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE PHARMACY AUTOMATION MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE PHARMACY AUTOMATION MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE PHARMACY AUTOMATION MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE PHARMACY AUTOMATION MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT (2023-2030)
FIGURE 43 EUROPE PHARMACY AUTOMATION MARKET: COMPANY SHARE 2022 (%)